维里迪安治疗 VRDN
$28.49 −$0.06 (-0.21%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.48 -0.04%
开盘$28.66
昨收$28.55
当日区间$27.86 – $29.47
成交量4.50M
市值$3.24B
市盈率（TTM）–
股息率–
VRDN 相关新闻
匹配 Viridian Therapeutics 或代码 VRDN 的头条新闻，按最新排序。
- RBC Capital Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $38 正面
- Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy Rating
- A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $41
- Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $39 正面
- Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $43
- Goldman Sachs Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $40 正面
- Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $40
- Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $39
- Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $26
- Wells Fargo Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $31
- Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $40 正面
- A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $43
- Jefferies Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $30 正面
- Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Fortrea Holdings Inc. (FTRE)
- A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $35
暂无评论——快来第一个聊聊 VRDN。
登录后参与讨论。